KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $56.1 million.

  • Edwards Lifesciences' Tax Provisions rose 3783.78% to $56.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $235.8 million, marking a year-over-year increase of 6711.55%. This contributed to the annual value of $152.1 million for FY2024, which is 19.69% down from last year.
  • Latest data reveals that Edwards Lifesciences reported Tax Provisions of $56.1 million as of Q3 2025, which was up 3783.78% from $64.3 million recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Tax Provisions high stood at $70.3 million for Q1 2025, and its period low was $10.9 million during Q4 2022.
  • For the 5-year period, Edwards Lifesciences' Tax Provisions averaged around $47.5 million, with its median value being $51.1 million (2021).
  • Per our database at Business Quant, Edwards Lifesciences' Tax Provisions crashed by 7341.46% in 2022 and then surged by 22150.0% in 2025.
  • Edwards Lifesciences' Tax Provisions (Quarter) stood at $41.0 million in 2021, then tumbled by 73.41% to $10.9 million in 2022, then soared by 212.84% to $34.1 million in 2023, then soared by 32.26% to $45.1 million in 2024, then increased by 24.39% to $56.1 million in 2025.
  • Its last three reported values are $56.1 million in Q3 2025, $64.3 million for Q2 2025, and $70.3 million during Q1 2025.